Bank of New York Mellon’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,868
| Closed | -$5.47K | – | 4504 |
|
|
2022
Q4 | $5.47K | Sell |
12,868
-100
| -0.8% | -$50 | ﹤0.01% | 4447 |
|
|
2022
Q3 | $9K | Hold |
12,968
| – | – | ﹤0.01% | 4517 |
|
|
2022
Q2 | $9K | Sell |
12,968
-88
| -0.7% | -$75 | ﹤0.01% | 4560 |
|
|
2022
Q1 | $14K | Hold |
13,056
| – | – | ﹤0.01% | 4633 |
|
|
2021
Q4 | $15K | Hold |
13,056
| – | – | ﹤0.01% | 4603 |
|
|
2021
Q3 | $30K | Hold |
13,056
| – | – | ﹤0.01% | 4487 |
|
|
2021
Q2 | $39K | Sell |
13,056
-2,380
| -15% | -$6.69K | ﹤0.01% | 4353 |
|
|
2021
Q1 | $47K | Buy |
+15,436
| New | +$56.7K | ﹤0.01% | 4272 |
|
|
2019
Q2 | – | Sell |
-44
| Closed | -$41K | – | 4308 |
|
|
2019
Q1 | $41K | Sell |
44
-1
| -2% | -$1.06K | ﹤0.01% | 4110 |
|
|
2018
Q4 | $47K | Buy |
45
+33
| +275% | +$79.2K | ﹤0.01% | 4067 |
|
|
2018
Q3 | $33K | Sell |
12
-1
| -8% | -$2.83K | ﹤0.01% | 4171 |
|
|
2018
Q2 | $35K | Sell |
13
-33
| -72% | -$95.1K | ﹤0.01% | 4132 |
|
|
2018
Q1 | $170K | Buy |
46
+2
| +5% | +$8.7K | ﹤0.01% | 3962 |
|
|
2017
Q4 | $219K | Hold |
44
| – | – | ﹤0.01% | 3914 |
|
|
2017
Q3 | $228K | Buy |
44
+1
| +2% | +$6.17K | ﹤0.01% | 3835 |
|
|
2017
Q2 | $310K | Buy |
+43
| New | +$321K | ﹤0.01% | 3804 |
|
Other funds holding VIVE
Bank of New York Mellon's VIVE Position: Q1 2023 in Review
Bank of New York Mellon sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 12,868 shares — an estimated $5.47K sold.
Bank of New York Mellon first reported a position in VIVE in Q2 2017 and held it in 16 quarters. The position peaked at $310K in Q2 2017. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- Bank of New York Mellon reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 12,868 VIVEVE MED INC shares in Q1 2023, an estimated $5.47K.
- Bank of New York Mellon first reported a position in VIVEVE MED INC in Q2 2017 and held it in 16 quarters.
- Bank of New York Mellon's VIVEVE MED INC position peaked at $310K in Q2 2017.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.